and PTH(1-84) are 95% and 55%, respectively [4, 5] .
(where M is the molecular weight of PTH, P abs the bioavailability, and m the mass of PTH). Using this calculation, 100 µg of PTH(1-84) is equivalent to 25 μg of teriparatide {100 μg×(55/95)×4,115/9,426= 25 μg} and these are the approximate doses used in the treatment of postmenopausal osteoporosis.
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